Why Hercules Capital (HTGC) Is Back In The Spotlight
Hercules Capital (HTGC) stock moved slightly lower in the latest session, giving investors a fresh prompt to reassess the business development company’s recent returns, income profile, and how its lending model fits into their portfolios.
At a share price of US$17.63, Hercules Capital has seen short term momentum cool slightly after its recent run. A 30 day share price return of 2.2% and a 90 day share price return of 14.11% feed into a more modest year to date share price decline of 6.52%, while longer term investors are still sitting on a 1 year total shareholder return of 1.79% and double digit total shareholder returns over 3 and 5 years.
Compare Hercules Capital's recent pullback and long term total returns with a hand picked group of income focused lenders and BDCs in the 11 dividend fortresses.
After the mix of recent gains and a softer near term trend, the question now is whether Hercules Capital at US$17.63 still offers enough upside potential for the risk you are taking, as the valuation section makes clear next.
Most Popular Narrative: 8.9% Undervalued
Against Hercules Capital’s last close at $17.63, the most widely followed narrative points to a fair value of about $19.36, based on a 9.3% discount rate and long term cash flow assumptions.
The increasing trend among startups and high-growth enterprises to seek non-bank, specialty lending amid regulatory constraints on traditional banks expands Hercules' pipeline, fueling portfolio growth and supporting higher long-term earnings.
Want to see what is behind this valuation gap for Hercules Capital? The narrative focuses on measured revenue growth, resilient margins, and a future earnings multiple that contrasts with today. Curious which specific forecasts have the most impact on that fair value.
Result: Fair Value of $19.36 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, investors also need to factor in rising competition in venture lending, as well as Hercules Capital’s concentrated exposure to technology and life sciences, which could pressure returns if conditions turn.
Find out about the key risks to this Hercules Capital narrative.
Next Steps
With Hercules Capital presenting both potential risks and rewards, now is a good time to review the full picture yourself and stress test your own thesis. To help with that, review the 3 key rewards and 2 important warning signs.
Looking for more investment ideas beyond Hercules Capital?
If you are serious about building a stronger portfolio, do not stop with Hercules Capital. Use the Simply Wall Street Screener to uncover stocks that better match your goals.
- Target potential mispricing by reviewing companies that screen as 47 high quality undervalued stocks based on solid fundamentals and current market expectations.
- Prioritise resilience by scanning a list of solid balance sheet and fundamentals (53 results) that can help you focus on businesses with stronger financial footing.
- Hunt for overlooked opportunities by checking a curated set of 17 high quality undiscovered gems that other investors might not be watching yet.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com